Have you ever heard the term “digital PCR” (Polymerase Chain Reaction)? That technology was of such interest to Bio-Rad Laboratories, Inc., that it just paid $162 million to acquire QuantaLife, Inc., the company that developed this digital PCR technology. The deal was announced on October 5. In the press release, it was noted that, “QuantaLife
Tag: pcr technology
IT’S BEEN A BUSY YEAR AND I HOPE NO ONE THINKS we’ve been remiss by not mentioning a milestone anniversary until now. On the other hand, I personally can’t recall reading about this anniversary elsewhere in the lab industry press during 2005. So maybe I am among the few to call attention to the fact
SPECIALTY LABORATORIES RESTORING STABILITY IN SPECIMEN VOLUME
IT’S NO SURPRISE THAT COMPETITORS of Specialty Laboratories, Inc. have been willing to spread a variety of rumors about the laboratory company, given its well-publicized troubles with government regulators last year.
Notwithstanding these rumors, the reality at Specialty Labs is quite different. On April 24, the company, based in Santa
CEO SUMMARY: Diagnostic manufacturers will begin to face the same controversy over public access to diagnostic testing technology that has dogged pharmaceutical companies in recent years. Public health officials and the military are unhappy with how Bio-Rad and its HIV-2 licensees have failed to provide the United States with a rapid HIV-2 test.
EXPECT MORE CONTROVERSY
SUNQUEST REAFFIRMS LONG-TERM COMMITMENT TO COPATHPLUS PRODUCT
EXPECT A FASCINATING competitive battle in the market for anatomic pathology software now that Cerner Corporation is acquiring Dynamic Healthcare Technologies, Inc. (DHT)
DHT is the developer and owner of CoPathPlus™ , used by many pathology group practices around the country. One authorized reseller of CoPathPlus is Sunquest Information
DNA DIAGNOSTICS MARKET GROWTH TO BE DOMINATED BY PCR TECHNOLOGY
FOR THE YEAR 2000, total DNA diagnostic technology sales were estimated to be $517 million. By 2005, this number should increase to $771 million, a growth rate of 8.4% per year.
This is the conclusion of Laura Roth, author of “The DNA Diagnostics Market,” a study recently
CEO SUMMARY: During the years of sustained bad financial news that dogged the major laboratories, there was a reluctance to speak publicly about any aspect of the laboratory business. That era seems to be ending, as LabCorp and the other national laboratories become friendlier and more accessible. A trip to LabCorp’s headquarters in Burlington, North